Movatterモバイル変換


[0]ホーム

URL:


EP2143465B1 - Electrode cuffs - Google Patents

Electrode cuffs
Download PDF

Info

Publication number
EP2143465B1
EP2143465B1EP09251749AEP09251749AEP2143465B1EP 2143465 B1EP2143465 B1EP 2143465B1EP 09251749 AEP09251749 AEP 09251749AEP 09251749 AEP09251749 AEP 09251749AEP 2143465 B1EP2143465 B1EP 2143465B1
Authority
EP
European Patent Office
Prior art keywords
housing
nerve
electrodes
insulating elements
cavities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Not-in-force
Application number
EP09251749A
Other languages
German (de)
French (fr)
Other versions
EP2143465A1 (en
Inventor
Tamir Ben-David
Shai Ayal
Ehud Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BioControl Medical Ltd
Original Assignee
BioControl Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioControl Medical LtdfiledCriticalBioControl Medical Ltd
Publication of EP2143465A1publicationCriticalpatent/EP2143465A1/en
Application grantedgrantedCritical
Publication of EP2143465B1publicationCriticalpatent/EP2143465B1/en
Not-in-forcelegal-statusCriticalCurrent
Anticipated expirationlegal-statusCritical

Links

Images

Classifications

Definitions

Landscapes

Description

    FIELD OF THE INVENTION
  • The present invention relates generally to electrical stimulation of tissue, and specifically to methods and devices for regulating the stimulation of nerves.
  • BACKGROUND OF THE INVENTION
  • A number of patents and articles describe methods and devices for stimulating nerves to achieve a desired effect. Often these techniques include a design for an electrode or electrode cuff.
  • US Patent 6,907,295 to Gross et al., which is assigned to the assignee of the present application, describes apparatus for applying current to a nerve. A cathode is adapted to be placed in a vicinity of a cathodic longitudinal site of the nerve and to apply a cathodic current to the nerve. A primary inhibiting anode is adapted to be placed in a vicinity of a primary anodal longitudinal site of the nerve and to apply a primary anodal current to the nerve. A secondary inhibiting anode is adapted to be placed in a vicinity of a secondary anodal longitudinal site of the nerve and to apply a secondary anodal current to the nerve, the secondary anodal longitudinal sice being closer to the primary anodal longitudinal site than to the cathodic longitudinal site.
  • US Patent Application Publication 2006/0106441 to Ayal et al., which is assigned to the assignee of the present application, describes apparatus for applying current to a nerve, including a housing, adapted to be placed in a vicinity of the nerve, and at least one cathode and at least one anode, fixed to the housing. The apparatus further includes two or more passive electrodes, fixed to the housing, and a conducting element, which electrically couples the passive electrodes to one another.
  • US Patents 4,608,985 to Crish et al. and4,649,936 to Ungar et al., describe electrode cuffs for selectively blocking orthodromic action potentials passing along a nerve trunk, in a manner intended to avoid causing nerve damage.
  • PCT Patent Publication WO 01/10375 to Felsen et al., describes apparatus for modifying the electrical behavior of nervous tissue. Electrical energy is applied with an electrode to a nerve in order to selectively inhibit propagation of an action potential.
  • US Patent 5,755,750 to Petruska et al., describes techniques for selectively blocking different size fibers of a nerve by applying direct electric current between an anode and a cathode that is larger than the anode.
  • US Patent 5,824,027 Hoffer et al., describes a nerve cuff having one or more sets of electrodes for selectively recording electrical activity in a nerve or for selectively stimulating regions of the nerve. Each set of electrodes is located in a longitudinally-extending chamber between a pair of longitudinal ridges which project into the bore of the nerve cuff. The ridges are electrically insulating and serve to improve the selectivity of the nerve cuff. The ridges seal against an outer surface of the nerve without penetrating the nerve. In an embodiment, circumferential end sealing ridges extend around the bore at each end of the longitudinal ridges, and are described as enhancing the electrical and/or fluid isolation between different ones of the longitudinally-extending chambers.
  • US Patent 4,628,942 to Sweeney et al., describes an annular electrode cuff positioned around a nerve trunk for imposing electrical signals on to the nerve trunk for the purpose of generating unidirectionally propagated action potentials. The electrode cuff includes an annular cathode having a circular passage therethrough of a first diameter. An annular anode has a larger circular passage therethrough of a second diameter, which second diameter is about 1.2 to 3.0 times the first diameter. A non-conductive sheath extends around the anode, cathode, and nerve trunk. The anode and cathode are placed asymmetrically to one side of the non-conductive sheath.
  • As defined byRattay, in an article entitled, "Analysis of models for extracellular fiber stimulation," IEEE Transactions on Biomedical Engineering, Vol. 36, no. 2, p. 676 (1989), the activation function (AF) of an unmyelinated axon is the second spatial derivative of the electric potential along an axon. In the region where the activation function is positive, the axon depolarizes, and in the region where the activation function is negative, the axon hyperpolarizes. If the activation function is sufficiently positive, then the depolarization will cause the axon to generate an action potential; similarly, if the activation function is sufficiently negative, then local blocking of action potentials transmission occurs. The activation function depends on the current applied, as well as the geometry of the electrodes and of the axon.
  • For a given electrode geometry, the equation governing the electrical potential is:σU=4πj,
    Figure imgb0001

    where U is the potential, σ is the conductance tensor specifying the conductance of the various materials (electrode housing, axon, intracellular fluid, etc.), and j is a scalar function representing the current source density specifying the locations of current injection. The activation function is found by solving this partial differential equation for U. If an unmyelinated axon is defined to lie in the z direction, then the activation function is:AF=2Uz2.
    Figure imgb0002
  • In a simple, illustrative example of a point electrode located a distance d from the axis of an axon in a uniformly-conducting medium with conductance σ, the two equations above are solvable analytically, to yield:AF=Iel4πσ2z2-d2z2+d22.5,
    Figure imgb0003

    where Iel is the electrode current. It is seen that when σ and d are held constant, and for a constant positive Iel (to correspond to anodal current), the minimum value of the activation function is negative, and is attained at z = 0, i.e., at the point on the nerve closest to the source of the anodal current. Thus, the most negative point on the activation function corresponds to the place on a nerve where hyperpolarization is maximized, namely at the point on the nerve closest to the anode.
  • Additionally, this equation predicts positive "lobes" for the activation function on either side of z = 0, these positive lobes peaking in their values at a distance which is dependent on each of the other parameters in the equation. The positive values of the activation function correspond to areas of depolarization, a phenomenon typically associated with cathodic current, not anodal current. However, it has been shown that excess anodal current does indeed cause the generation of action potentials adjacent to the point on a nerve corresponding to z = 0, and this phenomenon is therefore called the "virtual cathode effect." (An analogous, but reverse phenomenon, the "virtual anode effect" exists responsive to excess cathodic stimulation.)
  • The Rattay article also describes techniques for calculating the activation function for nerves containing myelinated axons. The activation function in this case varies as a function of the diameter of the axon in question. Thus, the activation function calculated for a 1 micron diameter myelinated axon is different from the activation function calculated for a 10 micron diameter axon.
  • The following patents may be of interest:
  • The following articles may be of interest:
  • The following articles describe techniques using cuff electrodes to selectively excite peripheral nerve fibers distant from an electrode without exciting nerve fibers close to the electrode:
  • SUMMARY OF THE INVENTION
  • In an exemplary arrangement, an electrode cuff for applying current to a nerve comprises a housing, which is configured to placed at least partially around the nerve, and a plurality of insulating elements arranged at respective longitudinal positions along the housing such that an inner surface of the housing and pairs of the insulating elements define respective cavities (i.e., spaces surrounded by portions of the cuff) at respective longitudinal positions along the housing. The cuff further comprises one or more electrodes, fixed to the housing in fewer than all of the cavities. In other words, at least one of the cavities defined by a pair of the insulating elements does not have an electrode positioned therein. The electrode cuff is typically configured such that, after placement of the cuff, respective contact surfaces of the insulating elements at least partially come in physical contact with the nerve, or substantially in physical contact with the nerve, e.g., are less than about 0.5 mm from the surface of the nerve. As used in the present application, including in the claims, an "electrode" is an electrically conductive element that includes at least one surface that is not electrically insulated.
  • Providing the one or more empty cavities results in less physical contact between the contact surfaces of the insulating elements and the nerve for a cuff of a given length, than in a cuff of the same length without such an empty cavity. As a result, providing the empty cavities tends to reduce constriction of the nerve by the cuff, which may reduce side-effects of application of the cuff to the nerve. Providing the empty cavity does not have a material impact on the activation function achieved by the electrode cuff.
  • For some applications, providing a cuff having an increased length along the nerve is desirable, e.g., because such an increased length provides greater space for a distribution of electrodes that enables achievement of a desired activation function that could not be achieved with a shorter cuff. Providing the empty cavity enables the lengthening of the cuff without a concomitant increase in insulating element contact surface area.
  • There is therefore provided, in accordance with an embodiment of the present invention, apparatus for application to a nerve of a subject, including:
    • an electrode cuff, which comprises:
      • a housing, configured to be placed at least partially around the nerve so as to define an inner surface of the housing that faces the nerve; and
      • a plurality of insulating elements coupled to the inner surface of the housing at respective insulating element longitudinal positions along the housing, such that the inner surface of the housing and pairs of the insulating elements define a plurality of cavities at respective cavity longitudinal positions along the housing;
      • the apparatus further comprising:
        • a plurality of electrodes, which comprise one cathode electrode, one anode electrode and at least one further cathode electrode or anode electrode, the electrodes of said plurality of electrodes being fixed to the housing and
        • a control unit, coupled to the electrodes, and configured to drive at least a portion of the electrodes to apply a current to the nerve; wherein
        • at least one of the cavities is an empty cavity that does not have an electrode positioned therein, and wherein the apparatus is characterized in that:
          • the empty cavity is between and directly adjacent along the cuff to two cavities containing two respective anode electrodes, or two cavities containing two respective cathode electrodes.
  • Typically, the insulating elements are shaped so as to define respective contact surfaces, and the housing and the insulating elements are configured such that the contact surfaces are positioned less than 0.5 mm from a surface cf the nerve when the housing is placed at least partially around the nerve. For some applications, the housing and the insulating elements are configured such that the contact surfaces at least partially come in physical contact with the nerve when the housing is placed at least partially around the nerve. Typically, a length that at least one of the insulating elements protrudes from the housing toward the nerve when the housing is placed at least partially around the nerve is at least 0.5 mm.
  • For some applications, the electrodes are fixed to the housing in a number of the cavities, wherein a difference between the number of the cavities and a total number of the cavities is an integer between 1 and 3, inclusive, such that between 1 and 3 of the cavities do not have any of the electrodes fixed therein.
  • In an embodiment, the housing has a length of between 10 mm and 14 mm, an outer radius of between 4 mm and 8 mm, an inner radius of between 3 mm and 6 mm, the insulating elements have an outer radius of between 3 mm and 6 mm, and an inner radius of between 2 mm and 3.5 mm, and the plurality of insulating elements includes exactly seven insulating elements, respective edges of which are positioned within the cuff at the following respective distances from one end of the cuff: 0.0 mm, between 1.3 and 1.7 mm, between 2.7 and 3.3 mm, between 5.1 and 6.3 mm, between 7.1 and 8.7 mm, between 8.5 and 10.3 mm, and between 10.2 and 12.4 mm, and the insulating elements having the following respective widths: between 0.7 and 0.9 mm, between 0.7 and 0.9 mm, between 1.4 and 1.8 mm, between 0.7 and 0.9 mm, between 0.7 and 0.9 mm, between 1.1 and 1.3 mm, and between 0.7 and 0.9 mm.
  • For some applications, the one or more cavities may include at least four cavities, and the electrodes may be fixed to the housing in at least three of the cavities.
  • For some applications, the apparatus further includes two or more passive electrodes, and the apparatus further includes a conducting element, which electrically couples the passive electrodes to one another.
  • In an embodiment, the plurality of insulating elements includes at least seven insulating elements, which are arranged along the housing such that the inner surface of the housing and the pairs of insulating elements define first, second, third, fourth, fifth, and sixth cavities, the first cavity closest to an end of the housing, the second adjacent to the first, the third adjacent to the second, the fourth adjacent to the third, the fifth adjacent to the fourth, and the sixth adjacent to the fifth; the at least one cathode electrode includes at least one first cathode electrode and at least one second cathode electrode; at least a first one of the passive electrodes is fixed to the housing in the first cavity; the at least one anode electrode is fixed to the housing in the second cavity; the at least one first cathode electrode is fixed to the housing in the third cavity; no electrodes are fixed to the housing in the fourth cavity; the at least one second cathode electrode is fixed to the housing in the fifth cavity; and at least a second one of the passive electrodes is fixed to the housing in the sixth cavity.
  • BRIEF DESCRIPTION OF THE DRAWINGS
    • Fig. 1 is schematic, cross-sectional illustration of an electrode cuff for applying current to a nerve, in accordance with respective embodiments of the present invention;
    • Fig. 2 is a schematic, cross-sectional illustration of another electrode cuff for applying current to a nerve;
    • Figs. 3 and 4 are graphs modeling calculated activation functions, respectively, when current is applied using electrode cuffs similar to those shown inFigs. 1 and2, respectively;
    • Fig. 5 is a schematic, longitudinal cross-sectional view of another electrode cuff for applying current to a nerve; and
    • Fig 6 is a schematic, cross-sectional illustration of yet another electrode cuff for applying current to a nerve.
    DETAILED DESCRIPTION OF EMBODIMENTS
  • Fig. 1 is a schematic, cross-sectional illustration of anelectrode cuff 20 for applying current to anerve 30, in accordance with an embodiment of the present invention.Electrode cuff 20 comprises ahousing 32 which defines an outer surface of the cuff when the cuff is placed at least partially aroundnerve 30.Housing 32 typically comprises an elastic, electrically-insulating material such as silicone or polyurethane, which may have, for example, a Shore A of between about 35 and about 70, such as about 40.
  • Electrode cuff 20 further comprises a plurality of insulatingelements 34 that are arranged at respective positions along the housing, and are typically fixed to aninner surface 37 ofhousing 32 that facesnerve 30 when the electrode cuff is placed at least partially around the nerve. Insulatingelements 34 typically comprise an elastic, electrically-insulating material such as silicone or silicone copolymer, which, for some applications, is softer than that ofhousing 32, for example, a Shore A of between about 10 and about 30, such as about 10.Electrode cuff 20 is typically configured such that, after placement of the cuff on the nerve, respective contact surfaces 36 of insulatingelements 34 at least partially come in physical contact with the nerve, or substantially in physical contact with the nerve, e.g., are less than about 0.5 mm from the surface of the nerve. For some applications, a length that at least one of insulatingelements 34 protrudes fromhousing 32 towardnerve 30 is at least 0.5 mm, such as at least 1 mm. For some applications, insulatingelements 34 andhousing 32 are constructed as separate elements that are coupled to one another, while for other applications, the insulating elements and housing are constructed as a single integrated element that is shaped to define the insulating elements and housing.
  • Insulatingelements 34 typically comprise one or more (such as exactly two)end insulating elements 38 arranged at or near respective ends of the cuff, and two or more internalinsulating elements 40 arranged at respective positions along the cuff between the end insulating elements.End insulating elements 38 extend alongnerve 30 in order to electrically isolate a portion of the nerve withinelectrode cuff 20 from a portion of the nerve outside the electrode cuff.
  • Inner surface 37 ofhousing 32 and pairs of insulatingelements 34 define arespective cavities 41 along the housing. (It is noted that some pairs of the insulating elements may not define a cavity, such as if two or more of the insulating elements are arranged in contact with one another.)
  • Electrode cuff 20 comprises a plurality ofelectrodes 42, fixed withinhousing 32 inrespective cavities 41 defined by respectivepairs insulating elements 34 andinner surface 37 ofhousing 32. At least one ofcavities 41 defined by a pair of the insulating elements does not have an electrode positioned therein. For example, in the embodiment shown inFig. 1, the insulating elements define sixcavities 41, a fourth one 43 of which (counting from the left in the figure) does not have an electrode positioned therein. For some applications, at least two, such as least three, of the cavities do not have electrodes positioned therein.Electrodes 42 are typically fixed toinner surface 37 ofhousing 32.
  • For some applications, at least one of the empty cavities has a length along the cuff of at least 0.5 mm, such as at least 0.7 mm, e.g., at least 1.4 mm or at least 2 mm, and/or no more than 5 mm, e.g., no more than 2 mm. For some applications, a length along the cuff of one of the empty cavities is between about 0.5 and about 5 times a length of one of the cavities that has an electrode therein, such as between about 1 and about 2 times the length.
  • At least one of the empty cavities is directly adjacent along the cuff to two cavities containing two respective anode electrodes, or to two cavities containing two respective cathode electrodes.
  • Providing the empty cavity results in less physical contact between contact surfaces 36 of insulatingelements 34 andnerve 30 for a cuff of a given length, than in a cuff of the same length without such an empty cavity. As a result, providing the empty cavity tends to reduce constriction of the nerve by the cuff, which may reduce side-effects of application of the cuff to the nerve. Providing the empty cavity does not have a material impact on the activation function achieved by the electrode cuff, as described hereinbelow with reference toFigs. 3 and 4.
  • Internalinsulating elements 40 are arranged so as to electricallyseparate electrodes 42, and to guide current from one of the electrodes towards the nerve prior to being taken up by another one of the electrodes. Typically (as shown), insulatingelements 34 are closer tonerve 30 than are the electrodes, i.e., the electrodes are recessed within the cavities. Alternatively (not shown), insulatingelements 34 are generally flush with the faces of the electrodes, such that the inner surfaces of insulating elements and the conductive surfaces of the electrode are equidistant from the nerve.
  • Electrodes 42 comprise onecathode electrode 46, oneanode electrode 48 and at least one further cathode electrode or anode electrode.Active electrodes 44 are coupled to an implantable orexternal control unit 50 byleads 52 and 54. For some applications, two or more of the active electrodes are shorted to one another inside or outside of the cuff, such as shown forcathode electrodes 46 inFig. 1.
  • In an embodiment of the present invention,electrode cuff 20 further comprises two or morepassive electrodes 60, fixed withinhousing 32, and a conductingelement 62, typically a wire, which electrically couples the passive electrodes to one another. A "passive electrode," as used in the present application including the claims, is an electrode that is electrically "device-coupled" to neither (a) any circuitry that is electrically device-coupled to any of the cathode electrodes or anode electrodes, nor (b) an energy source. "Device-coupled" means coupled, directly or indirectly, by components of a device, and excludes coupling via tissue of a subject. (It is noted that the passive electrodes may be passive because of a software-controlled setting of the electrode assembly, and that the software may intermittently change the setting such that these electrodes are not passive.) To "passively electrically couple," as used in the present application including the claims, means to couple using at least one passive electrode and no non-passive electrodes.Passive electrodes 60 and conductingelement 62 create an additional electrical path for the current, such as an additional path for the current that would otherwise leakoutside electrode cuff 20 and travel around the outside of the housing through tissue of the subject. For some applications, conductingelement 62 comprises at least onepassive element 64, such as a resistor, capacitor, and/or inductor. In this embodiment, end insulatingelements 38 help direct any current that leaks fromactive electrodes 44 through the electrical path created bypassive electrodes 60 and conductingelement 62. For some applications,active electrodes 44 are positioned withinhousing 32 longitudinally between the two or more passive electrodes 60 (as shown inFig. 1). Alternatively, at least one of the passive electrodes is positioned between the at least one cathode electrode and the at least one anode electrode (configuration not shown).
  • In an embodiment of the present invention,electrode cuff 20 comprises one or morepassive electrodes 60 which are not electrically device-coupled to one another. For some applications, the electrode cuff comprises exactly onepassive electrode 60. A separate conducting element, typically a wire, is coupled to each passive electrode at a first end of the conducting element. The second end of the conducting element terminates at a relatively-remote location in the body of the subject that is at a distance of at least 1 cm, e.g., at least 2 or 3 cm, fromelectrode cuff 20. The remote location in the body thus serves as a ground for the passive electrode. For some applications, an electrode is coupled to the remote end of the conducting element, so as to increase electrical contact with tissue at the remote location.
  • For some applications,housing 32 has a length of between about 10 and about 14 mm, e.g., about 12.1 mm; an outer radius of between about 4 and about 8 mm, e.g., about 5.9 mm; and an inner radius of between about 3 and about 6 mm, e.g., about 4.5 mm. For some applications, insulatingelements 34 have an outer radius of between about 3 and about 6 mm, e.g., about 4.5 mm (the outer radius of the insulating elements is typically equal to the inner radius of the housing), and an inner radius of between about 2 and about 3.5 mm. For some applications in whichcuff 20 comprises exactly twoend insulating elements 38 and exactly five internalinsulating elements 40, respective edges of insulatingelements 34 are positioned withincuff 32 at the following distances from one end of the cuff: 0.0 mm, between 1.3 and 1.7 mm (e.g., 1.5 mm), between 2.7 and 3.3 mm (e.g., 3.0 mm), between 5.1 and 6.3 mm (e.g., 5.7 mm), between 7.1 and 8.7 mm (e.g., 7.9 mm), between 8.5 and 10.3 mm (e.g., 9.4 mm), and between 10.2 and 12.4 mm (e.g., 11.3 mm), and the insulating elements having the following respective widths: between 0.7 and 0.9 mm (e.g., 0.8 mm), between 0.7 and 0.9 mm (e.g., 0.8 mm), between 1.4 and 1.8 mm (e.g., 1.6 mm), between 0.7 and 0.9 mm (e.g., 0.8 mm), between 0.7 and 0.9 mm (e.g., 0.8 mm), between 1.1 and 1.3 mm (e.g., 1.2 mm), and between 0.7 and 0.9 mm (e.g., 0.8 mm). For some applications,electrodes 42 comprise Pt/Ir. For some applications, as shown inFig. 1,electrodes 42 are shaped as rings (e.g.,reference numeral 60 andleftmost reference numeral 42 inFig. 1 refer to a single ring electrode). The rings may have an outer radius that equals, or is slightly greater or less than, the inner radius ofhousing 32.
  • In an embodiment of the present invention, at least some of the electrodes do not comprise ring electrodes. Instead, each of at least one ofnon-empty cavities 41 has fixed therein a plurality of electrodes positioned at least partially circumferentially around a central axis of the cuff. In other words,electrodes 42 arefirst electrodes 42, fixed withinhousing 32 inrespective cavities 41, andcuff 20 comprises at least onesecond electrode 42, fixed withinhousing 32 in one of thecavities 41 in which one of thefirst electrodes 42 is fixed. For some applications, the plurality of electrodes within a single cavity are circumferentially separated from one another by one or more circumferentially arranged insulating elements.
  • In an embodiment of the present invention, at least one of the one or more ofcavities 41 which are empty in the embodiments described hereinabove, instead has fixed therein one or more electrodes that are not electrically device-coupled (as defined hereinabove) to any elements of the device outside of the cavity. These electrodes thus do not serve the normal function of electrodes in an electrode cuff, i.e., conducting current to and/or from tissue.
  • In an embodiment of the present invention,nerve 30 is a vagus nerve, andelectrode cuff 20 is configured to be placed at least partially around the vagus nerve such thatanode electrode 48 is more proximal to the brain than arecathode electrodes 46.
  • Fig. 2 is a schematic, cross-sectional illustration of anelectrode cuff 120 for applying current tonerve 30.Electrode cuff 120 is identical toelectrode cuff 20, described hereinabove with reference toFig. 1, except thatcuff 120 lackscavity 43 ofcuff 20, which, as mentioned above, does not have one ofelectrodes 42 positioned therein. Instead of the two internalinsulating elements 40 that definecavity 43 incuff 20,cuff 120 has a single, elongated insulatingelement 130, having a length along the housing equal to the sum of the lengths along the cuff ofcavity 43 and the two internalinsulating elements 40 that definecavity 43 incuff 20.
  • Reference is made toFigs. 3 and 4, which are graphs modeling calculated activation functions 200 and 202, respectively, when current is applied using electrode cuffs similar to those shown inFigs. 1 and2, respectively. These activation functions model myelinated nerve fibers having a diameter of 1 micrometer, over a portion of the length ofnerve 30, at a radius of 1.2 mm from the axis of the nerve. For the purposes of modeling these activation functions, (a) twocathode electrodes 46 are placed at longitudinal sites on the nerve labeled z = 2.25 mm and z = -1.65 mm, respectively, (b)anode electrode 48 is placed at a longitudinal site z = -4.15 mm, and (c) twopassive electrodes 60 are placed at longitudinal sites z = 4.15 mm and z = -5.65 mm, respectively. All of the electrodes are placed at a radius of R = 2.5 mm from the axis ofnerve 30, which has a radius of 1.35 mm. The cavity of activation function 200 (Fig. 3) is at z = 0.4 mm. The inner surfaces of all of the insulating elements (i.e., the surfaces closest to the nerve) are placed at a radius R = 1.5 mm from the axis ofnerve 30.
  • A comparison of activation functions 200 and 202 shows that the two activation functions are nearly identical, which demonstrates that providingempty cavity 43 does not have a material impact on the activation function achieved by the electrode cuff.
  • For some applications,electrode cuff 20 is configured to selectively stimulate fibers of the nerve having certain diameters, such as by using techniques described in one or more of the patent applications referenced hereinbelow. For example,control unit 50 may drivecathode electrode 46 to apply to nerve 30 a stimulating current, which is capable of inducing action potentials in a first set and a second set of nerve fibers of the nerve, and driveanode electrode 48 to apply to the nerve an inhibiting current, which is capable of inhibiting the induced action potentials traveling in the second set of nerve fibers, the nerve fibers in the second set having generally larger diameters than the nerve fibers in the first set.
  • For some applications,electrode cuff 20 is configured to apply unidirectional stimulation to the nerve, such as by using techniques described in one or more of the patent applications referenced hereinbelow. For example,control unit 50 may driveanode electrode 48 to apply an inhibiting current capable of inhibiting device-induced action potentials traveling in a non-therapeutic direction innerve 30. For some applications,electrode cuff 20 comprises primary and secondary anode electrodes, the primary anode electrode located between the secondary anode electrode and the cathode electrode. The secondary anode electrode is typically adapted to apply a current with an amplitude less than about one half an amplitude of a current applied by the primary anode electrode.
  • Reference is made toFig. 5, which is a schematic, cross-sectional view of anelectrode cuff 320 for applying current tonerve 30.Electrode cuff 320 comprises ahousing 332 which defines an outer surface of the cuff when the cuff is placed at least partially aroundnerve 30.Housing 332 typically comprises an elastic, electrically-insulating material such as silicone or polyurethane, which may have, for example, a Shore A of between about 35 and about 70, such as about 40.Electrode cuff 20 further comprises a plurality ofm insulating elements 334 which are arranged at respective circumferential positions around the housing, and which extend longitudinally along at least a portion of a length of the housing. Insulatingelements 334 typically comprise an elastic, electrically-insulating material such as silicone or silicone copolymer, which, for some applications, is softer than that ofhousing 332, for example, a Shore A of between about 10 and about 30, such as about 10.Electrode cuff 320 is typically configured such that, after placement of the cuff on the nerve, respective contact surfaces 336 of insulatingelements 334 come in physical contact with the nerve, cr substantially in physical contact with the nerve, e.g., are less than about 0.5 mm from the surface of the nerve. For some applications, a length that at least one of insulatingelements 334 protrudes fromhousing 332 toward nerve 330 is at least 0.5 mm, such as at least 1 mm. For some applications, insulatingelements 334 andhousing 332 are constructed as separate elements that are coupled to one another, while for other applications, the insulating elements and housing are constructed as a single integrated element that is shaped to define the insulating elements and housing.
  • Together, insulatingelements 334 define a plurality ofn cavities 341 aroundhousing 332, wherein n is less than or equal to m (the number of insulating elements, as mentioned above). Typically, n equals m. Alternatively, n is less than m, such as if two or more of the insulating elements are arranged in contact with one another. It is noted that thecavities 341 ofelectrode cuff 320 are oriented in a direction that is generally perpendicular to that ofcavities 41 ofelectrode cuff 20 ofFig. 1. Insulatingelements 334 ofelectrode cuff 320 run along the nerve in a direction parallel with a longitudinal axis of the nerve, while insulatingelements 34 ofelectrode cuff 20 surround all or a portion of the nerve.
  • Electrode cuff 320 comprises a plurality ofp electrodes 342, fixed withinhousing 332 inrespective cavities 341 defined by two of insulatingelements 334, wherein p is less than n. In other words, at least one ofcavities 341 defined by a pair of the insulating elements does not have an electrode positioned therein. For example, in the embodiment shown inFig. 5, the insulating elements define twelvecavities 341, half of which do not have an electrode positioned therein. For some applications, p equals a fraction of n, such as 2/3, 1/2, 1/3, or 1/4.
  • For some applications,electrode cuff 320 comprises elements described hereinabove with reference toFig. 1, such active and/or passive electrodes, and/or a control unit coupled to the cuff with leads.
  • Fig. 6 is a schematic, cross-sectional illustration of anelectrode cuff 420 for applying current tonerve 30.Electrode cuff 420 comprises a housing 432 which defines an outer surface of the cuff when the cuff is placed at least partially aroundnerve 30. Housing 432 typically comprises an elastic, electrically-insulating material such as silicone or polyurethane, which may have, for example, a Shore A of between about 35 and about 70, such as about 40.
  • Electrode cuff 420 further comprises at least two, e.g., exactly two, insulatingelements 434 that are arranged at respective positions along the housing, and are typically fixed to aninner surface 437 of the housing that facesnerve 30 when the cuff is placed at least partially around the nerve. Insulatingelements 434 typically comprise an elastic, electrically-insulating material such as silicone or silicone copolymer, which, for some applications, is softer than that of housing 432, for example, a Shore A of between about 10 and about 30, such as about 10.Electrode cuff 420 is typically configured such that, after placement of the cuff on the nerve, respective contact surfaces 436 of insulatingelements 434 come in physical contact with the nerve, or substantially in physical contact with the nerve, e.g., are less than about 0.5 mm from the surface of the nerve. For some applications, a length that at least one of insulatingelements 434 protrudes from housing 432 towardnerve 30 is at least 0.5 mm, such as at least 1 mm. For some applications, insulatingelements 434 and housing 432 are constructed as separate elements that are coupled to one another, while for other applications, the insulating elements and housing are constructed as a single integrated element that is shaped to define the insulating elements and housing. Insulatingelements 434 extend alongnerve 30 in order to electrically isolate a portion of the nerve withinelectrode cuff 420 from a portion of the nerve outside the electrode cuff.
  • Insulatingelements 434 are positioned along housing 432 such thatend portions 456 of housing 432 extend beyond the insulating elements toward respectivelongitudinal ends 458 of the housing. In other words, the insulating elements are longitudinally recessed from ends 458 of the housing. In addition, insulatingelements 434 are positioned along housing 432 such thatinner surface 437 of housing 432 and one or more pairs of the insulating elements define one or morerespective cavities 441 along the housing. In the exemplary configuration shown inFig. 6, the inner surface of the housing and exactly one pair of the insulating elements define exactly one cavity.
  • Cuff 420 comprises at least twoelectrodes 442, each of which is fixed toinner surface 437 of housing 432 at at least a portion of one ofend portions 456 of housing 432. At least one ofcavities 441, e.g., all ofcavities 441 and/or exactly one of the cavities, does not have an electrode positioned therein. In other words, the electrodes are fixed to the housing in fewer than all of the cavities, e.g., in none of the cavities. For some applications, at least one of the empty cavities has a length along the cuff of at least 0.5 mm, such as at least 0.7 mm, e.g., at least 1.4 mm or at least 2 mm, and/or no more than 5 mm, e.g., no more than 3 mm or no more than 3 cm.
  • Providing the empty cavity results in less physical contact betweencontact surfaces 436 of insulatingelements 434 andnerve 30 for a cuff of a given length, than in a cuff of the same length without such an empty cavity. As a result, providing the empty cavity tends to reduce constriction of the nerve by the cuff, which may reduce side-effects of application of the cuff to the nerve. Providing the empty cavity does not have a material impact on the activation function achieved by the electrode cuff.
  • Electrodes 442 comprise at least one active, i.e., stimulating and/or sensing, electrode, such as at least onecathode electrode 446 and at least oneanode electrode 448. The active electrodes are coupled to an implantable orexternal control unit 450 byleads 452 and 458. For some applications, active electrode configurations and/or stimulation techniques are used which are described in one or more of the patent applications referenced hereinbelow. For some applications, two or more of the active electrodes are shorted to one another inside or outside of the cuff, such as shown forcathode electrodes 46 inFig. 1. For some applications,cuff 420 comprises one or more passive electrodes, as described hereinabove with reference toFig. 1.
  • In an embodiment of the present invention, at least some ofelectrodes 442 comprise ring electrodes. Alternatively, the electrodes do not comprise ring electrodes. Instead, fixed to at least a portion of each of end portions are a plurality of electrodes positioned at least partially circumferentially around a central axis of the cuff. In other words,electrodes 442 arefirst electrodes 442, andcuff 420 comprises at least onesecond electrode 442. For some applications, the plurality of electrodes are circumferentially separated from one another by one or more circumferentially arranged insulating elements.
  • In an alternative arrangement, at least one of the one or more ofcavities 441 which are empty in the arrangement described hereinabove, instead has fixed therein one or more electrodes that are not electrically device-coupled (as defined hereinabove) to any elements of the device outside of the cavity. These electrodes thus do not serve the normal function of electrodes in an electrode cuff, i.e., conducting current to and/or from tissue.
  • In an alternative arrangement, insulatingelements 434 are not positioned so as to define anycavities 441. For example, insulatingelements 434 may comprise exactly one insulating element, which may have a length of at least 0.5 mm, such as at least 1 mm.
  • It is noted that although electrode cuffs 20, 320 and 420 and their elements are generally shown in the figures and described herein in a cylindrical configuration, other geometrical configurations, such as non-rotationally symmetric configurations, are also suitable for applying the principles of the present invention. In particular,housings 32, 332 or 432 of the electrode cuffs (and the electrodes themselves) may form a complete circle around nerve 3C, or they may define an arc between approximately 0 and 90 degrees, between 90 and 180 degrees, between 180 and 350 degrees, or between 350 and 359 degrees around the nerve. For some applications,electrode cuff 20 or 420 comprises electrodes that form rings around the nerve, such thathousing 32 surrounds the electrodes.
  • Techniques described herein can be practiced in combination with techniques described with reference toFigs. 2,3, and/or 6 ofUS Patent Application 11/280,884 to Ayal et al., filed November 15, 2005, which published asUS Patent Application Publication 2006/0106441, and which is assigned to the assignee of the present application. For example:
    • for some applications, a closest distance between cathode electrodes 46 (i.e., the distance between the respective cathode electrodes' edges that are closest to one another) is equal to at least a radius R ofnerve 30, e.g., at least 1.5 times the radius of the nerve, as described with reference toFig. 2 of the '441 publication; and/or
    • for some applications, end insulatingelements 38 are elongated, as described with reference toFig. 6 of the '441 publication.
  • As used in the present patent application, including in the claims, "longitudinal" means along the length of, and does not mean "around" or "circumferential." For example, "longitudinal positions" along the housing means positions along the length of the housing, rather than positions arranged circumferentially around a longitudinal axis of the housing or the nerve. Such longitudinal positions might be measured in mm from one end of the housing.
  • Techniques and apparatus described in one or more of the following applications can be combined with techniques and apparatus described herein:
    • USProvisional Patent Application 60/383,157 to Ayal et al., filed May 23, 2002, entitled, "Inverse recruitment for autonomic nerve systems,"
    • International Patent ApplicationPCT / IL02 / 00068 to Cohen et al., filed January 23, 2002, entitled, "Treatment of disorders by unidirectional nerve stimulation," published asWO 03/018113 A1, andUS Patent Application 10/488,334, published asUS 2004/0243182 A1, in the national stage thereof,
    • US Patent Application 09/944,913 to Cohen and Gross, filed August 31, 2001, entitled, "Treatment of disorders by unidirectional nerve stimulation," published asUS 2003/0045914 A1, which issued asUS Patent 6, 684, 105,
    • US Patent Application 09/824,682 to Cohen and Ayal, filed April 4, 2001, entitled "Method and apparatus for selective control of nerve fibers," published asUS 2002/0099419 A1,
    • US Patent Application 10/205,475 to Gross et al., filed July 24, 2002, entitled, "Selective nerve fiber stimulation for treating heart conditions," published asUS 2003/0045909 A1,
    • US Patent Application 10/205,474 to Gross et al., filed July 24, 2002, entitled, "Electrode assembly for nerve control," published asUS 2003/0050677 A1, which issued asUS Patent 6,907,295,
    • International Patent ApplicationPCT / IL03 / 00431 to Ayal et al., filed May 23, 2003, entitled, "Selective nerve fiber stimulation for treating heart conditions," published asWO 03/099377 A1,
    • International Patent ApplicationPCT / IL03 / 00430 to Ayal et al., filed May 23, 2003, entitled, "Electrode assembly for nerve control," and published asWO 03/099373 A2,US Patent Application 10/529,149, published asUS 2006/0116739 A1, in the national stage thereof,
    • US Patent Application 10/719,659 to Ben David et al., filed November 20, 2003, entitled, "Selective nerve fiber stimulation for treating heart conditions," published asUS 2004/0193231 A1,
    • US Patent Application 11/022,011 to Cohen et al., filed December 22, 2004, entitled, "Construction of electrode assembly for nerve control," published asUS 2006/0136024 A1,
    • US Patent Application 11/234,877 to Ben-David et al., filed September 22, 2005, entitled, "Selective nerve fiber stimulation," published asUS 2006/0100668 A1, and
    • US Patent Application 11/280,884 to Ayal et al., filed November 15, 2005, entitled, "Techniques for nerve stimulation," which published asUS Patent Application Publication 2006/0106441.

Claims (11)

  1. Apparatus for application to a nerve (30) of a subject, comprising:
    an electrode cuff (20), which comprises:
    a housing (32), configured to be placed at least partially around the nerve (30) so as to define an inner surface (37) of the housing (32) that faces the nerve (30) ; and
    a plurality of insulating elements (34) coupled to the inner surface (37) of the housing (32) at respective insulating element longitudinal positions along the housing (32), such that the inner surface (37) of the housing (32) and pairs of the insulating elements (34) define a plurality of respective cavities (41) at respective cavity longitudinal positions along the housing (32);
    the apparatus further comprising:
    a plurality of electrodes (42), which comprise one cathode electrode (46), one anode electrode (4B) and at least one further cathode electrode (46) or anode electrode (48), the electrodes (42) of said plurality of electrodes being fixed to the housing, and
    a control unit (50), coupled to the electrodes (42), and configured to drive at least a portion of the electrodes (42) to apply a current to the nerve (30);
    wherein
    at least one of the cavities (41) is an empty cavity (43) that does not have an electrode positioned therein, and wherein the apparatus ischaracterized in that:
    the empty cavity (43) is between and directly adjacent along the cuff (20) to two cavities (41) containing two respective anode electrodes (48), or two cavities (41) containing two respective cathode electrodes (46).
  2. The apparatus according to claim 1, wherein the insulating elements (34) are shaped so as to define respective contact surfaces (36), and wherein the housing (32) and the insulating elements (34) are configured such that the contact surfaces (36) are suitable for being positioned less than 0.5 mm from a surface of the nerve (30) when the housing (32) is placed at least partially around the nerve (3C).
  3. The apparatus according to claim 1, wherein the insulating elements (34) are shaped so as to define respective contact surfaces (36), and wherein the housing (32) and the insulating elements (34) are configured such that the contact surfaces (36) are suitable for at least partially coming in physical contact with the nerve (30) when the housing (32) is placed at least partially around the nerve (30).
  4. The apparatus according to claim 1, wherein the electrodes (42) are fixed to the housing (32) in a number of the cavities (41), wherein a difference between the number of the cavities (41) and a total number of the cavities (41, 43) is an integer between 1 and 3, inclusive, such that between 1 and 3 of the cavities (43) do not have any of the electrodes (42) fixed therein.
  5. The apparatus according to claim 1,
    wherein the housing (32) has a length of between 10 mm and 14 mm, an outer radius of between 4 mm and 8 mm, an inner radius of between 3 mm and 6 mm,
    wherein the insulating elements (34) have an outer radius of between 3 mm and 6 mm, and an inner radius of between 2 mm and 3.5 mm, and
    wherein the plurality of insulating elements (34) comprises exactly seven insulating elements (34), respective edges of which are positioned within the housing (32) at the following respective distances from one end of the housing (32): 0.0 mm, between 1.3 and 1.7 mm, between 2.7 and 3.3 mm, between 5.1 and 6.3 mm, between 7.1 and 8.7 mm, between 8.5 and 10.3 mm, and between 10.2 and 12.4 mm, and the insulating elements (34) having the following respective widths: between 0.7 and 0.9 mm, between 0.7 and 0.9 mm, between 1.4 and 1.8 mm, between 0.7 and 0.9 mm, between C.7 and 0.9 mm, between 1.1 and 1.3 mm, and between C.7 and 0.9 mm.
  6. The apparatus according to claim 1, wherein the electrodes (42) comprise ring electrodes.
  7. The apparatus according to claim 1, wherein the one or more cavities (42) include at least four cavities (42), and wherein the electrodes (42) are fixed to the housing (32) in at least three of the cavities (41).
  8. The apparatus according to claim 1, wherein the apparatus further comprises two or more passive electrodes (60), and wherein the apparatus further comprises a conducting element (62), which electrically couples the passive electrodes (60) to one another.
  9. The apparatus according to claim 8,
    wherein the plurality of insulating elements (34) includes at least seven insulating elements (34), which are arranged along the housing (32) such that the inner surface of the housing (32) and the pairs of insulating elements (34) define first, second, third, fourth, fifth, and sixth cavities, the first cavity closest to an end of the housing (32), the second adjacent to the first, the third adjacent to the second, the fourth adjacent to the third, the fifth adjacent to the fourth, and the sixth adjacent to the fifth,
    wherein the at least one cathode electrode (46) comprises at least one first cathode electrode (46) and at least one second cathode electrode (46),
    wherein at least a first one of the passive electrodes (60) is fixed to the housing (32) in the first cavity,
    wherein the at least one anode electrode (48) is fixed to the housing (32) in the second cavity,
    wherein the at least one first cathode electrode (46) is fixed to the housing (32) in the third cavity,
    wherein no electrodes are fixed to the housing (32) in the fourth cavity (43),
    wherein the at least one second cathode electrode (46) is fixed to the housing (32) in the fifth cavity, and
    wherein at least a second one of the passive electrodes (60) is fixed to the housing (32) in the sixth cavity.
  10. The apparatus according to claim 1, wherein a length that at least one of the insulating elements (34) protrudes from the housing (32) toward the nerve (30) when the housing (32) is placed at least partially around the nerve (30) is at least 0.5 mm.
  11. The apparatus according to claim 1, wherein at least two of the electrodes (42) are fixed to the housing (32) in one of the cavities 41).
EP09251749A2008-07-092009-07-07Electrode cuffsNot-in-forceEP2143465B1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US12/217,930US20100010603A1 (en)2008-07-092008-07-09Electrode cuffs

Publications (2)

Publication NumberPublication Date
EP2143465A1 EP2143465A1 (en)2010-01-13
EP2143465B1true EP2143465B1 (en)2012-10-03

Family

ID=40969406

Family Applications (1)

Application NumberTitlePriority DateFiling Date
EP09251749ANot-in-forceEP2143465B1 (en)2008-07-092009-07-07Electrode cuffs

Country Status (2)

CountryLink
US (1)US20100010603A1 (en)
EP (1)EP2143465B1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US9643022B2 (en)2013-06-172017-05-09Nyxoah SAFlexible control housing for disposable patch
US9849289B2 (en)2009-10-202017-12-26Nyxoah SADevice and method for snoring detection and control
US9855032B2 (en)2012-07-262018-01-02Nyxoah SATranscutaneous power conveyance device
US9943686B2 (en)2009-10-202018-04-17Nyxoah SAMethod and device for treating sleep apnea based on tongue movement
US9956393B2 (en)2015-02-242018-05-01Elira, Inc.Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US10052097B2 (en)2012-07-262018-08-21Nyxoah SAImplant unit delivery tool
US10118035B2 (en)2015-02-242018-11-06Elira, Inc.Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US10335302B2 (en)2015-02-242019-07-02Elira, Inc.Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US10376145B2 (en)2015-02-242019-08-13Elira, Inc.Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US10751537B2 (en)2009-10-202020-08-25Nyxoah SAArced implant unit for modulation of nerves
US10765863B2 (en)2015-02-242020-09-08Elira, Inc.Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10814137B2 (en)2012-07-262020-10-27Nyxoah SATranscutaneous power conveyance device
US10864367B2 (en)2015-02-242020-12-15Elira, Inc.Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
US11253712B2 (en)2012-07-262022-02-22Nyxoah SASleep disordered breathing treatment apparatus
US11957895B2 (en)2015-02-242024-04-16Elira, Inc.Glucose-based modulation of electrical stimulation to enable weight loss

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US6907295B2 (en)2001-08-312005-06-14Biocontrol Medical Ltd.Electrode assembly for nerve control
US8565896B2 (en)2010-11-222013-10-22Bio Control Medical (B.C.M.) Ltd.Electrode cuff with recesses
US7904176B2 (en)2006-09-072011-03-08Bio Control Medical (B.C.M.) Ltd.Techniques for reducing pain associated with nerve stimulation
US8571653B2 (en)*2001-08-312013-10-29Bio Control Medical (B.C.M.) Ltd.Nerve stimulation techniques
US8880192B2 (en)2012-04-022014-11-04Bio Control Medical (B.C.M.) Ltd.Electrode cuffs
US8718791B2 (en)2003-05-232014-05-06Bio Control Medical (B.C.M.) Ltd.Electrode cuffs
US10912712B2 (en)2004-03-252021-02-09The Feinstein Institutes For Medical ResearchTreatment of bleeding by non-invasive stimulation
US11207518B2 (en)*2004-12-272021-12-28The Feinstein Institutes For Medical ResearchTreating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
WO2009029614A1 (en)*2007-08-272009-03-05The Feinstein Institute For Medical ResearchDevices and methods for inhibiting granulocyte activation by neural stimulation
WO2009146030A1 (en)*2008-03-312009-12-03The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation of t-cell activity
US9662490B2 (en)2008-03-312017-05-30The Feinstein Institute For Medical ResearchMethods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
EP2355893B1 (en)*2008-11-182013-12-25Setpoint Medical CorporationDevices for optimizing electrode placement for anti-inflamatory stimulation
US9211410B2 (en)2009-05-012015-12-15Setpoint Medical CorporationExtremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en)*2009-10-302015-03-31Setpoint Medical CorporationModulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
WO2010144578A2 (en)2009-06-092010-12-16Setpoint Medical CorporationNerve cuff with pocket for leadless stimulator
WO2014169145A1 (en)2013-04-102014-10-16Setpoint Medical CorporationClosed-loop vagus nerve stimulation
US9833621B2 (en)2011-09-232017-12-05Setpoint Medical CorporationModulation of sirtuins by vagus nerve stimulation
EP2515996B1 (en)2009-12-232019-09-18Setpoint Medical CorporationNeural stimulation devices and systems for treatment of chronic inflammation
US12172017B2 (en)2011-05-092024-12-24Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders
WO2012154865A2 (en)2011-05-092012-11-15Setpoint Medical CorporationSingle-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8934992B2 (en)*2011-09-012015-01-13Inspire Medical Systems, Inc.Nerve cuff
US8918190B2 (en)2011-12-072014-12-23Cyberonics, Inc.Implantable device for evaluating autonomic cardiovascular drive in a patient suffering from chronic cardiac dysfunction
US8630709B2 (en)2011-12-072014-01-14Cyberonics, Inc.Computer-implemented system and method for selecting therapy profiles of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction
US8577458B1 (en)2011-12-072013-11-05Cyberonics, Inc.Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with leadless heart rate monitoring
US8600505B2 (en)2011-12-072013-12-03Cyberonics, Inc.Implantable device for facilitating control of electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction
US10188856B1 (en)2011-12-072019-01-29Cyberonics, Inc.Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction
US8918191B2 (en)2011-12-072014-12-23Cyberonics, Inc.Implantable device for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration
US8700150B2 (en)2012-01-172014-04-15Cyberonics, Inc.Implantable neurostimulator for providing electrical stimulation of cervical vagus nerves for treatment of chronic cardiac dysfunction with bounded titration
US8571654B2 (en)2012-01-172013-10-29Cyberonics, Inc.Vagus nerve neurostimulator with multiple patient-selectable modes for treating chronic cardiac dysfunction
US9572983B2 (en)2012-03-262017-02-21Setpoint Medical CorporationDevices and methods for modulation of bone erosion
CN104582787A (en)*2012-04-022015-04-29生物控制医疗(Bcm)有限公司Electrode cuffs
US8688212B2 (en)2012-07-202014-04-01Cyberonics, Inc.Implantable neurostimulator-implemented method for managing bradycardia through vagus nerve stimulation
US8923964B2 (en)2012-11-092014-12-30Cyberonics, Inc.Implantable neurostimulator-implemented method for enhancing heart failure patient awakening through vagus nerve stimulation
US9452290B2 (en)2012-11-092016-09-27Cyberonics, Inc.Implantable neurostimulator-implemented method for managing tachyarrhythmia through vagus nerve stimulation
US9643008B2 (en)2012-11-092017-05-09Cyberonics, Inc.Implantable neurostimulator-implemented method for enhancing post-exercise recovery through vagus nerve stimulation
US9643011B2 (en)2013-03-142017-05-09Cyberonics, Inc.Implantable neurostimulator-implemented method for managing tachyarrhythmic risk during sleep through vagus nerve stimulation
US9999773B2 (en)2013-10-302018-06-19Cyberonics, Inc.Implantable neurostimulator-implemented method utilizing multi-modal stimulation parameters
US9511228B2 (en)2014-01-142016-12-06Cyberonics, Inc.Implantable neurostimulator-implemented method for managing hypertension through renal denervation and vagus nerve stimulation
US9272143B2 (en)2014-05-072016-03-01Cyberonics, Inc.Responsive neurostimulation for the treatment of chronic cardiac dysfunction
US9713719B2 (en)2014-04-172017-07-25Cyberonics, Inc.Fine resolution identification of a neural fulcrum for the treatment of chronic cardiac dysfunction
US9409024B2 (en)2014-03-252016-08-09Cyberonics, Inc.Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction
US9415224B2 (en)2014-04-252016-08-16Cyberonics, Inc.Neurostimulation and recording of physiological response for the treatment of chronic cardiac dysfunction
US9950169B2 (en)2014-04-252018-04-24Cyberonics, Inc.Dynamic stimulation adjustment for identification of a neural fulcrum
US9737716B2 (en)2014-08-122017-08-22Cyberonics, Inc.Vagus nerve and carotid baroreceptor stimulation system
US9533153B2 (en)2014-08-122017-01-03Cyberonics, Inc.Neurostimulation titration process
US9770599B2 (en)2014-08-122017-09-26Cyberonics, Inc.Vagus nerve stimulation and subcutaneous defibrillation system
US11311725B2 (en)2014-10-242022-04-26Setpoint Medical CorporationSystems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
US9504832B2 (en)2014-11-122016-11-29Cyberonics, Inc.Neurostimulation titration process via adaptive parametric modification
US11406833B2 (en)2015-02-032022-08-09Setpoint Medical CorporationApparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)2016-01-132020-03-24Setpoint Medical CorporationSystems and methods for establishing a nerve block
CN108882885A (en)2016-01-202018-11-23赛博恩特医疗器械公司 Control of vagus nerve stimulation
US11471681B2 (en)2016-01-202022-10-18Setpoint Medical CorporationBatteryless implantable microstimulators
EP3405255A4 (en)2016-01-202019-10-16Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTION RECHARGE SYSTEMS
US10583304B2 (en)2016-01-252020-03-10Setpoint Medical CorporationImplantable neurostimulator having power control and thermal regulation and methods of use
EP3664889B1 (en)2017-08-112024-02-21Inspire Medical Systems, Inc.Cuff electrode
US11173307B2 (en)2017-08-142021-11-16Setpoint Medical CorporationVagus nerve stimulation pre-screening test
US11260229B2 (en)2018-09-252022-03-01The Feinstein Institutes For Medical ResearchMethods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
WO2020210786A1 (en)2019-04-122020-10-15Setpoint Medical CorporationVagus nerve stimulation to treat neurodegenerative disorders
EP4566539A1 (en)2020-05-212025-06-11The Feinstein Institutes for Medical ResearchSystems and methods for vagus nerve stimulation

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2201104A (en)1938-11-211940-05-14Samuel H DavisPaste brush holder
US4535785A (en)1982-09-231985-08-20Minnesota Mining And Manufacturing Co.Method and apparatus for determining the viability and survival of sensori-neutral elements within the inner ear
US4573481A (en)1984-06-251986-03-04Huntington Institute Of Applied ResearchImplantable electrode array
US4628942A (en)1984-10-111986-12-16Case Western Reserve UniversityAsymmetric shielded two electrode cuff
US4602624A (en)1984-10-111986-07-29Case Western Reserve UniversityImplantable cuff, method of manufacture, and method of installation
US4649936A (en)1984-10-111987-03-17Case Western Reserve UniversityAsymmetric single electrode cuff for generation of unidirectionally propagating action potentials for collision blocking
US4608985A (en)1984-10-111986-09-02Case Western Reserve UniversityAntidromic pulse generating wave form for collision blocking
US5095905A (en)1990-06-071992-03-17Medtronic, Inc.Implantable neural electrode
US5199430A (en)1991-03-111993-04-06Case Western Reserve UniversityMicturitional assist device
US5215086A (en)1991-05-031993-06-01Cyberonics, Inc.Therapeutic treatment of migraine symptoms by stimulation
IT1260485B (en)1992-05-291996-04-09 PROCEDURE AND DEVICE FOR THE TREATMENT OF THE OBESITY OF A PATIENT
US5400784A (en)1993-10-151995-03-28Case Western Reserve UniversitySlowly penetrating inter-fascicular nerve cuff electrode and method of using
US5487756A (en)1994-12-231996-01-30Simon Fraser UniversityImplantable cuff having improved closure
US5755750A (en)1995-11-131998-05-26University Of FloridaMethod and apparatus for selectively inhibiting activity in nerve fibers
DE19609471A1 (en)1996-03-011997-11-13Biotronik Mess & Therapieg Electrode arrangement
US5833664A (en)*1996-10-081998-11-10Seare, Jr.; William J.Noded cuffs for transcutaneous or intrabody prosthetic devices
US5824027A (en)1997-08-141998-10-20Simon Fraser UniversityNerve cuff having one or more isolated chambers
US6341236B1 (en)1999-04-302002-01-22Ivan OsorioVagal nerve stimulation techniques for treatment of epileptic seizures
AU6465400A (en)1999-08-042001-03-05Impulse Dynamics N.V.Inhibition of action potentials
US6456866B1 (en)1999-09-282002-09-24Dustin TylerFlat interface nerve electrode and a method for use
US6684105B2 (en)2001-08-312004-01-27Biocontrol Medical, Ltd.Treatment of disorders by unidirectional nerve stimulation
US6907295B2 (en)2001-08-312005-06-14Biocontrol Medical Ltd.Electrode assembly for nerve control
US6600956B2 (en)2001-08-212003-07-29Cyberonics, Inc.Circumneural electrode assembly
US7627384B2 (en)2004-11-152009-12-01Bio Control Medical (B.C.M.) Ltd.Techniques for nerve stimulation
US8116881B2 (en)*2004-06-102012-02-14Bio Control Medical (B.C.M.) LtdElectrode assembly for nerve control
US7761168B2 (en)*2006-07-132010-07-20Yossi GrossPeltier unidirectional and selective nerve stimulation

Cited By (29)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US10716940B2 (en)2009-10-202020-07-21Nyxoah SAImplant unit for modulation of small diameter nerves
US9849289B2 (en)2009-10-202017-12-26Nyxoah SADevice and method for snoring detection and control
US11857791B2 (en)2009-10-202024-01-02Nyxoah SAArced implant unit for modulation of nerves
US9943686B2 (en)2009-10-202018-04-17Nyxoah SAMethod and device for treating sleep apnea based on tongue movement
US9950166B2 (en)2009-10-202018-04-24Nyxoah SAAcred implant unit for modulation of nerves
US11273307B2 (en)2009-10-202022-03-15Nyxoah SAMethod and device for treating sleep apnea
US10898717B2 (en)2009-10-202021-01-26Nyxoah SADevice and method for snoring detection and control
US10751537B2 (en)2009-10-202020-08-25Nyxoah SAArced implant unit for modulation of nerves
US11253712B2 (en)2012-07-262022-02-22Nyxoah SASleep disordered breathing treatment apparatus
US10814137B2 (en)2012-07-262020-10-27Nyxoah SATranscutaneous power conveyance device
US9855032B2 (en)2012-07-262018-01-02Nyxoah SATranscutaneous power conveyance device
US11730469B2 (en)2012-07-262023-08-22Nyxoah SAImplant unit delivery tool
US10918376B2 (en)2012-07-262021-02-16Nyxoah SATherapy protocol activation triggered based on initial coupling
US10716560B2 (en)2012-07-262020-07-21Nyxoah SAImplant unit delivery tool
US10052097B2 (en)2012-07-262018-08-21Nyxoah SAImplant unit delivery tool
US11642534B2 (en)2013-06-172023-05-09Nyxoah SAProgrammable external control unit
US9643022B2 (en)2013-06-172017-05-09Nyxoah SAFlexible control housing for disposable patch
US10512782B2 (en)2013-06-172019-12-24Nyxoah SARemote monitoring and updating of a medical device control unit
US11298549B2 (en)2013-06-172022-04-12Nyxoah SAControl housing for disposable patch
US9956393B2 (en)2015-02-242018-05-01Elira, Inc.Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US11197613B2 (en)2015-02-242021-12-14Elira, Inc.Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US10143840B2 (en)2015-02-242018-12-04Elira, Inc.Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US10765863B2 (en)2015-02-242020-09-08Elira, Inc.Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10118035B2 (en)2015-02-242018-11-06Elira, Inc.Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US10335302B2 (en)2015-02-242019-07-02Elira, Inc.Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US11712562B2 (en)2015-02-242023-08-01Elira, Inc.Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10864367B2 (en)2015-02-242020-12-15Elira, Inc.Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
US10376145B2 (en)2015-02-242019-08-13Elira, Inc.Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US11957895B2 (en)2015-02-242024-04-16Elira, Inc.Glucose-based modulation of electrical stimulation to enable weight loss

Also Published As

Publication numberPublication date
EP2143465A1 (en)2010-01-13
US20100010603A1 (en)2010-01-14

Similar Documents

PublicationPublication DateTitle
EP2143465B1 (en)Electrode cuffs
EP2340870B1 (en)Apparatus for nerve stimulation
US8718791B2 (en)Electrode cuffs
US6907295B2 (en)Electrode assembly for nerve control
US8615294B2 (en)Electrode devices for nerve stimulation and cardiac sensing
US8116881B2 (en)Electrode assembly for nerve control
CA2702326C (en)Neurostimulator and method for regulating the same
US7844346B2 (en)Electrode assembly for nerve control
US8478428B2 (en)Helical electrode for nerve stimulation
US20060136024A1 (en)Construction of electrode assembly for nerve control
JP7471294B2 (en) IMPLANTABLE MEDICAL LEAD HAVING MOVABLE CONDUCTOR - Patent application
US20230141622A1 (en)Minimally invasive neurostimulation device with sensing capability
US11420053B2 (en)Diagnostic, neurostimulating, and therapeutic method applied to biological targets that are naturally integrated to each other
Sabetian et al.Directionally-sensitive peripheral nerve recording: Bipolar nerve cuff design
SabetianImproved Peripheral Nerve Recording with a Small Form-Factor Nerve Electrode; A Novel Bipolar Nerve Cuff Design

Legal Events

DateCodeTitleDescription
PUAIPublic reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text:ORIGINAL CODE: 0009012

17PRequest for examination filed

Effective date:20090715

AKDesignated contracting states

Kind code of ref document:A1

Designated state(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

RIN1Information on inventor provided before grant (corrected)

Inventor name:AYAL, SHAI

Inventor name:COHEN, EHUD

Inventor name:BEN-DAVID, TAMIR

GRAPDespatch of communication of intention to grant a patent

Free format text:ORIGINAL CODE: EPIDOSNIGR1

GRASGrant fee paid

Free format text:ORIGINAL CODE: EPIDOSNIGR3

GRAA(expected) grant

Free format text:ORIGINAL CODE: 0009210

AKDesignated contracting states

Kind code of ref document:B1

Designated state(s):AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR

REGReference to a national code

Ref country code:GB

Ref legal event code:FG4D

REGReference to a national code

Ref country code:AT

Ref legal event code:REF

Ref document number:577692

Country of ref document:AT

Kind code of ref document:T

Effective date:20121015

Ref country code:CH

Ref legal event code:EP

REGReference to a national code

Ref country code:IE

Ref legal event code:FG4D

REGReference to a national code

Ref country code:DE

Ref legal event code:R096

Ref document number:602009010156

Country of ref document:DE

Effective date:20121129

REGReference to a national code

Ref country code:AT

Ref legal event code:MK05

Ref document number:577692

Country of ref document:AT

Kind code of ref document:T

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:SI

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

REGReference to a national code

Ref country code:NL

Ref legal event code:VDEP

Effective date:20121003

REGReference to a national code

Ref country code:LT

Ref legal event code:MG4D

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:NL

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:LT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:ES

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130114

Ref country code:HR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:SE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:NO

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130103

Ref country code:IS

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130203

Ref country code:FI

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:GR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130104

Ref country code:LV

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:CY

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:PT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130204

Ref country code:PL

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:BE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:AT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:BG

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20130103

Ref country code:EE

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:CZ

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:DK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:SK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PLBENo opposition filed within time limit

Free format text:ORIGINAL CODE: 0009261

STAAInformation on the status of an ep patent application or granted ep patent

Free format text:STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:IT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:RO

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

26NNo opposition filed

Effective date:20130704

REGReference to a national code

Ref country code:DE

Ref legal event code:R097

Ref document number:602009010156

Country of ref document:DE

Effective date:20130704

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:MC

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

REGReference to a national code

Ref country code:CH

Ref legal event code:PL

REGReference to a national code

Ref country code:IE

Ref legal event code:MM4A

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:LI

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20130731

Ref country code:CH

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20130731

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:IE

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20130707

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:SM

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:MT

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

Ref country code:TR

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:HU

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date:20090707

Ref country code:LU

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20130707

Ref country code:MK

Free format text:LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date:20121003

REGReference to a national code

Ref country code:FR

Ref legal event code:PLFP

Year of fee payment:8

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:GB

Payment date:20160721

Year of fee payment:8

Ref country code:DE

Payment date:20160722

Year of fee payment:8

PGFPAnnual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code:FR

Payment date:20160721

Year of fee payment:8

REGReference to a national code

Ref country code:DE

Ref legal event code:R119

Ref document number:602009010156

Country of ref document:DE

GBPCGb: european patent ceased through non-payment of renewal fee

Effective date:20170707

REGReference to a national code

Ref country code:FR

Ref legal event code:ST

Effective date:20180330

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:DE

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20180201

Ref country code:GB

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20170707

PG25Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code:FR

Free format text:LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date:20170731


[8]ページ先頭

©2009-2025 Movatter.jp